Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Johnson & Johnson (

Bellwether Health Giant J&J Skids As Psoriasis Blockbuster Drags Top Line

Johnson & Johnson stock skidded Tuesday after light sales of blockbuster psoriasis treatment Stelara dragged the company's top line lower.

Investors Business Daily

Dow Jones Futures Rise On UnitedHealth After Market Reversal; Tesla Breaks Lower

Futures rose on UnitedHealth earnings after Monday's ugly market reversal. Tesla is set to undercut lows after its "dark day."

Investors Business Daily

JNJ Earnings Forecast - Is Pharmaceutical Industry Set for Shake-up?

As pharma titan Johnson & Johnson (JNJ) gears up to unveil its first-quarter results on April 16, 2024, anticipation looms over the pharmaceutical industry. JNJ’s recent acquisitions signal the company’s strategic expansions, and given its history as one of the prominent pharma companies, is JNJ’s forecast as stunning? Let us…

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

Stock Index Futures are Higher after Wholesale Prices Increased Less Than Expected in March

June S&P 500 E-Mini futures (ESM24) are up 0.02%, and June Nasdaq 100 E-Mini futures (NQM24) are up 0.17%% this morning, after the release of the PPI data.

Barchart

Stock Index Futures Slip as Rate Cut Hopes Fade, U.S. PPI Data and ECB Decision in Focus

June S&P 500 E-Mini futures (ESM24) are down -0.36%, and June Nasdaq 100 E-Mini futures (NQM24) are down -0.30% this morning, signaling further losses on Wall Street after hotter-than-expected U.S. inflation data diminished hopes of early interest rate cuts by the Federal Reserve, while investors awaited crucial U.S. producer inflation…

Barchart

Johnson & Johnson Acquires Shockwave Medical For Billion

Johnson & Johnson invests billion to acquire Shockwave Medical, a leader in heart care technology.

Top News

4 Pharma Titans Making Waves in Wall Street

The pharma industry is well-positioned to remain buoyed, owing to the rise in chronic diseases, a growing elderly population, and the integration of advanced technologies. Given this backdrop, quality pharma stocks Bristol-Myers Squibb Company (BMY), Johnson & Johnson (JNJ), Novartis AG (NVS), and Merck & Co. (MRK), making waves in…

StockNews.com

3 Pharma Stocks With Prescription for Stability and Value in March

Amid rising healthcare demand globally, advancements in precision medicine, and the booming e-pharmacy market, the pharmaceutical industry is expected to witness significant long-term growth. Hence, fundamentally sound pharma stocks Dr. Reddy’s Laboratories (RDY), Ipsen (IPSEY), and Johnson & Johnson (JNJ), which boast low beta values and attractive valuation metrics, might…

StockNews.com

4 Top Dividend Kings to Earn Passive Income

Dividend Kings are companies with a long history of paying and increasing shareholder dividends, which signals strong financial health for investors looking to build a steady stream of passive income.

Barchart

20 Highest-Grossing Biotech Stocks: Giants Driving Innovation and Growth

Biotech stocks offers the potential for significant returns driven by breakthrough discoveries and advancements in healthcare, agriculture, and other industries.

International Business Times

Pfizer (PFE) vs. Johnson & Johnson (JNJ) - Analyzing Pharma Stocks for Upside Potential

The pharmaceutical industry is expected to witness robust growth over the coming years due to growing healthcare needs and advancements in technology. Given this positive backdrop, let’s analyze the upside potential of pharma stocks Pfizer (PFE) and Johnson & Johnson (JNJ).

StockNews.com

Senators ask CEOs why their drugs cost so much more in the U.S.

The Senate HELP committee questioned pharmaceutical CEOs about how much more Americans pay for the same drugs sold for less in Canada, Japan and Europe.

WEKU

Get all your
news in one place.

100’s of premium titles.
One news app.

Roll Call

Merck, Johnson & Johnson CEOs agree to appear before Senate HELP - Roll Call

Two drug company CEOs have agreed to testify before the Senate HELP Committee on drug prices, avoiding a scheduled subpoena vote on Jan. 31.

Investors Business Daily

Stock Market Continues To Rally; ASML, Netflix, Tesla, Intel Are Big Earnings Movers: Weekly Review

The market rally continued amid near-perfect economic data. ASML and Netflix were earning winners. Tesla and Intel dived on guidance.

Investors Business Daily

J&J Flashes A Sell Signal Despite A MedTech Beat That Bodes Well For Its Rivals

Johnson & Johnson beat fourth-quarter expectations Tuesday, helped by strength from its medtech segment. But JNJ stock toppled.

Investors Business Daily

Dow Jones Stocks: From 3M To Intel, A Big Earnings Week For Blue Chips

Eight Dow Jones stock report earnings this week. Several, including Verizon and 3M, are in buy zones or near buy points.

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

Johnson & Johnson (JNJ): Analyzing Signals Before Quarterly Earnings

Pharmaceutical powerhouse Johnson & Johnson (JNJ) is proactively driving innovation throughout the healthcare spectrum, thanks to its strong focus on innovative medicines and MedTech solutions. However, with the company’s fiscal fourth-quarter earnings on the horizon, could the stock be a wise portfolio addition? Keep reading to find out….

The Guardian - US

Families condemn Koch brothers over ploy to avoid asbestos compensation

Georgia-Pacific, owned by Koch Industries, employ controversial legal tactic to circumvent paying millions to sickened workers

Barchart

2 Dividend Kings Yielding Around 3% to Grab Now

High yields aren't the only reason to buy shares of dividend-paying stocks. For investors seeking quality dividend stocks for passive income, here's a look at two companies with long track records of raising shareholder payouts.

iMore

Apple's board of directors welcomes space program expert — Dr. Wanda Austin joins as Al Gore departs

Dr. Wanda Austin has joined Apple's board of directors, while former U.S. VP Al Gore has departed.

Barchart

Strength in Tech Stocks Powers the Overall Market Higher

What you need to know… The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +1.41%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.58%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +2.11%. Stocks on Monday settled moderately higher, with the...

Barchart

Stocks Mostly Higher on Strength in Tech and a Decline in Bond Yields

What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is up +0.51%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.17%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.20%. Stocks this morning are mixed, with the Dow Jones...

Barchart

Markets Today: Stocks Climb on M&A Activity and Lower Bond Yields

Morning Markets March E-Mini S&P 500 futures (ES H24) are up +0.06%, and March Nasdaq 100 E-Mini futures (NQH2 4) are up +0.18%. Stock index futures this morning are moderately higher. An increase in M&A activity supports stocks after Boston Scientific agreed to buy Axionics for $3.7 billion and Johnson...

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.